Ashworth et al., “Comparison of L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressant,” Cancer Res. 34:1353-1359 (1974). |
Baechtel, F. S., et al., “The influence of glutamine, its decomposition products, and glutaminase on the transformation of human lymphocytes,” Biochem. Biophys. Acta 421:33-43 (1976). |
Broome, J. D., “Evidence that the asparaginase activity of guinea pig serum is responsible for its anti-lymphoma effects,” Nature 191:1114-1115 (1961). |
Broome, J. D., “Factors which may influence the effectiveness of L-asparaginase as tumor inhibitors,” Br. J. Cancer 22:595-602 (1969). |
Campbell, H. A., et al., “Two asparaginases from Escherichia coli B: their separation, purification, and anti-tumor activity,” Biochemistry 6:721-730 (1967). |
Cao, S. & Zhao, G., “Chemical modification of enzyme molecules to improve their characteristics,” Annals of the New York Academy of Sciences: Enzyme Engineering 10a 613:460-467 (1990). |
Cheung, N. & Chau, K., “Antibody response to Escherichia coli L-asparaginase: Prognostic significance and clinical utility of antibody measurement,” Am. J. Pediatric Hematol. Oncol. 8:99-104 (1986). |
Clementi, A., “La desamidation enzmatique de l'asparagine chez les differentes especes-animals et la signification physiologique de sa presence dass l'organisme,” Arch. Intern. Physiol. 19:369-398 (1922). |
Cooney, D.A., et al., “L-asparaginase and L-asparagine metabolism,” Ann. Rev. Pharmacol. 10:421-440 (1970). |
Crowther, “L-Asparaginase and human malignant disease,” Nature 229:168-171 (1971). |
Distasio et al., “Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity,” Int. J. Cancer 30:343-347 (1982). |
Distasio, J. & Niedennan, A., “Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes,” J. Biol. Chem. 251:6929-6933 (1976). |
Distasio, J.A., et al., “Alteration in spleen lymphoid populations associated with specific amino acid depletion during L-asparaginase treatment,” Cancer Res. 42:252-258 (1982). |
Durden, D. L. & Distasio, J. A., “Comparison of the Immunosuppressive Effects of Asparaginases from Escherichia coli and Vibrio succinogenes,” Cancer Res. 40:1125-1129 (1980). |
Durden, D. L. & Distasio, J.A., “Characterization of the effects of asparaginases from Escherichia coli and a asparaginase from Vibrio succinogenes on specific cell-mediated cytotoxicity,” Int. J. Cancer 27:59-65 (1981). |
Durden, D. L., “A glutaminase-free asparaginase form Vibrio succinogenes lacking immunosuppression and toxicity,” Ph. D. Dissertation,University of Miami Medical School (1983). |
Durden, D. L., et al., “Kinetic analysis of hepatotoxicity associated with anti-neoplastic asparaginases,” Cancer Res. 43:1602-1605 (1983). |
El-Asmar, F.A. & Greenberg, D.H., “Studies on the mechanism of inhibition of tumor growth by glutaminase,” Cancer Res. 26:116-122 (1966). |
Gardner et al., “Lymphoid tumors in mice receiving steroid hormones,” Cancer Research 4:73-87 (1944). |
Habeeb, A.F.S.A., “Determination of free amino groups in proteins by trinitrobenzenesulfonic acid,” Analytical Biochemistry 14:328-336 (1966). |
Harlow and Lane in Antibodies, a Laboratory Manual, Cold Spring Harbor Laboratory, 1988. |
Hersh, E.M. & Brown, B.W., “Inhibition of immune response by glutamine antagonism: effect of azotomycin on lymphocyte blastogenesis,” Cancer Res. 31:834-840 (1980). |
Hersh, “L-Glutaminase: Suppression of lymphocyte blastogenic responses in vitro,” Science 172:736-738 (1971). |
Hochuli et al., “New metal chelate absorbents selective for protein and peptide containing neighboring histidine residues,” J. Chromatography 411:177-184 (1987). |
Howard, J. B. & Carpenter, F.H., “L-asparaginase from Erwinia carotovora: substrate specificity and enzymatic properties,” J. Biol. Chem. 247:1020-1030 (1972). |
Jack et al., “The effect of histidine ammonia-lyase on some murine tumors,” Leukemia Res. 7:421 (1983). |
Lubkowski et al., “Crystal structure and amino acid sequence of Wolinella succinogenes L-asparaginase,” Eur. J. Biochem. 241:201-207 (1996). |
Molecular Cloning, A Laboratory Manual, 2d ed., ed. Sambrook, et al., Cold Spring Harbor Laboratory Press, (1989) (Table of contents only). |
Ohno,, R. & Hersh, E. M., “Immunosuppressive effects of L-asparaginase,” Cancer Res. 30:1605-1611 (1970). |
Ortega, J.A., et al., “L-asparaginase, vincristine, and prednisone for the induction of first remission in acute lymphocytic leukemia,” Cancer Res. 37:535-540 (1977). |
Park, R. & Liu, K., “A role for Shc, grb2 and raf-1 in FcR1 signal relay,” J. Biol. Chem. 271:13342-13348 (1996). |
Schein et al., “The toxicity of E. coli asparaginase,” Cancer Res. 29:426-434 (1969). |
Schrek, R., et al., “Effect of L-glutaminase on transformation and DNA synthesis of normal lymphocytes,” Acta Haematol. 48:12-15 (1972). |
Schwartz, R.S., “Immunosuppression by L-asparaginase,” Nature 224:275-276 (1969). |
Simberkoff, M.S. & Thomas, L., “Reversal by L-glutamine of the inhibition of lymphocyte mitosis caused by E. coli asparaginase,” Proc. Soc. Exp. Biol. 133 642-644 (1970). |
Spiers, A.D.S., et al., “L-glutaminase/L-asparaginase: human pharmacology, toxicology, and activity in acute leukemia,” Cancer Treat. Rep. 63:1019-1024 (1979). |
Pastor et al., “Treatment of systemic lupus erythematosus with L-asparaginase: considerations on a case,” Revista do Hospital das Clinicas; Faculdade de Medicina da Universidade Sao Paulo, vol. 27, No. 3, pp. 129-133, May-Jun. 1972.* |
Rudinger, In Peptide Hormones, Parsons, Ed., pp. 2, 4 and 5, Jun. 1976.* |
Guan et al., “Primary cloining and expression of the Vibrio succinogenes L-asparaginase gene,” Shengwu Gongcheng Xuebao, vol. 4, No. 1, pp. 11-19, 1988.* |
Guan et al., “Primary cloning and expression of a gene encoding the antileukemia agent (asparaginase),” Chin. Sci. Bull., vol. 34, No. 5, pp. 436-437, 1989.* |
Wada et al., Antitumor Enzyme: Polyethylene glycol—Modified Asparaginase, Ann. NY Acad. Sci., vol. 613, pp. 96-108, 1990.* |
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” In The Protein folding Provblem and Terriary Structure Prediction, Merz, Jr. et al., Eds., Birkhauser Boston, pp. 492-494, 1994.* |
Thornton et al., “Protein Engineering”, Curr. Opinion in Biotech., vol. 6, No. 4, pp. 367-369, Aug. 1995. |